Cannabis Stock Update:
Let's Toke Business - Week of March 2nd
Enterprise Group
(TSX: $E.TO) Named Lead Sponsor for Let's Toke Business: The Commerce of
Cannabis
 |
| by Ted Ohashi MBA, CFA |
March 5, 2018 (Investorideas.com Newswire) Our Sponsor, Enterprise Group, Inc. [TSX: E] (a consolidator of
services to the energy sector) was included in The Well Street Journal’s
resource metrics’ chart for six Oil Field and Facility construction companies.
Enterprise
numbers were impressive including the lowest price/book at .04x ($0.37 vs.
$0.85). Since the resource decline began in 2014-15, the Company has been cash
flow positive, and a decisive return to profitability with Q4 2017 EPS of $0.02
and Q3 2017 EPS of $0.01. The Company is pleased with the activity in the first
part of Q1 2018.
From
Jan 29th Well Street: “Companies are moving from inward-looking cost-cutting
measures to seeking growth in an improving market. If you’re selling, make sure
you differentiate yourself. Those with proprietary products and services will
fare better in 2018 than the so-called ‘me-too’ businesses. Buyers will be
looking for stand-out companies that have achieved differentiation, strong
management teams and a broad customer
base”
Week Ended March 2nd, 2018
·
Ted Ohashi's recent
articles on Seeking Alpha..........p2
·
Cannabis stocks
adrift on an ebb tide..........p2
·
Do cannabis stocks
care what the Dow is doing?..........p5
·
Maricann has a
tough week..........p5
·
Aurora joins the
line at Shoppers Drug..........p5
·
ABcann closes $75
million bought deal financing..........p6
·
Cronos leads the
way to a Nasdaq listing..........p6
·
Lexaria deal with Biolog
paves the way for major inroads into the edibles market..........p6
·
In New Cannabis
Ventures, Alan Brochstein reviews cannabis stock performance..........p7
·
Emerald Health JV
License with Village Farms approved..........p8
Read: Complete
Report
Read this news in
full at http://www.investorideas.com/news/2018/cannabis/03051LetsTokeBusiness-TSXE.asp
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/News/Clientspecifics.asp Disclosure: Enterprise is a paid PR news and
social media client effective January 1 2018 for three months -five thousand
per month
Additional info regarding
BC Residents and global Investors: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of
each country
